Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Q/C Technologies, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q2 2024
- Shares held
- 37.2K
- −21.0K (−36.0%) vs. Q2 2024
- Total value
- $60.3K
- −$47.3K (−44.0%) vs. Q2 2024
- New holders
- 4
- 4 more added
- Sold out
- 6
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 12 | $69.8K |
| Q2 2025 | 33 | $65.3K |
| Q1 2025 | 24 | $69.0K |
| Q4 2024 | 25 | $145.8K |
| Q3 2024 | 20 | $60.3K |
| Q2 2024 | 23 | $114.6K |
| Q1 2024 | 20 | $1.38M |
| Q4 2023 | 50 | $1.64M |
| Q3 2023 | 51 | $2.52M |
| Q2 2023 | 48 | $6.51M |
| Q1 2023 | 50 | $6.98M |
| Q4 2022 | 43 | $4.49M |
| Q3 2022 | 43 | $9.94M |
| Q2 2022 | 39 | $10.3M |
| Q1 2022 | 35 | $22.4M |
| Q4 2021 | 41 | $27.1M |
| Q3 2021 | 28 | $41.8M |
| Q2 2021 | 23 | $30.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 1 | $2 | 0.00% | +1 | New |
| St. Johns Investment Management Company, LLC | 18 | $29 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $30 | 0.00% | +2+12.5% | Added |
| Newbridge Financial Services Group, Inc. | 34 | $55 | 0.00% | 00.0% | Unchanged |
| Arvest Investments, Inc. | 34 | $55 | 0.00% | 00.0% | Unchanged |
| ORG Wealth Partners, LLC | 34 | $55 | 0.00% | +34 | New |
| Harbor Investment Advisory, LLC | 90 | $146 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 99 | $159 | 0.00% | −167−62.8% | Reduced |
| Sandy Spring Bank | 116 | $188 | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 134 | $217 | 0.00% | +134 | New |
| Wells Fargo & Company | 167 | $271 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 227 | $368 | 0.00% | +34+17.6% | Added |
| Group One Trading, L.P. | 387 | $627 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 838 | $1.36K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,236 | $2.00K | 0.00% | +1,197+3,069.2% | Added |
| BlackRock, Inc. | 3,803 | $6.16K | 0.00% | +3,803 | New |
| Vanguard Group Inc | 13,999 | $22.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 15,969 | $25.9K | 0.00% | +1,559+10.8% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −15,822−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,688−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Anchor Investment Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |